D&PS

Daily Issue (Apr 10. 2018)

Interview
Interview with the CEOs, FDA-approved Medical Laser Device Manufacturer Based in Korea I

PICOCARE obtained FDA approval in 2017 and is a Nd:YAG picosecond laser that produces various wavelengths including 1064nm, 532nm, 595nm, and 660nm. It can be used in various pigmented lesions with little damage to the skin and high efficacy. We were actually behind other manufacturers in developing a picesecond laser because our internal advisory panel did not see a need to develop a picosecond laser. At the time, there was not enough evidence on the benefits of the picosecond laser and there was a lot of doubt whether investing in R&D would be fruitful. However, interest in this new laser began to grow and we felt it necessary to enter the picosecond laser market. I believe we were about a year and a half behind other manufacturers in developing the picosecond laser…

Latest Articles

Clinical Case Review